Clinical Trial Update: Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating everolimus after chemoembolization for liver metastases from digestive gastroenteropancreatic neuroendocrine tumors. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Neuroendocrine Tumors, Hepatic Metastases | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25